Receptor-selective retinoid agonists and teratogenic activity

Area of Science:

• Molecular Pharmacology
• Developmental Toxicology
• Teratology

Background:

• Retinoid signaling pathways involve retinoic acid receptors (RARs) and retinoid X receptors (RXRs).
• Understanding the role of specific RAR and RXR interactions in retinoid-induced birth defects (teratogenesis) is crucial.

Purpose of the Study:

• To investigate the teratogenic potential of various retinoids selective for RAR and RXR receptors.
• To correlate in vitro receptor binding and transcriptional activity with in vivo developmental toxicity.
• To explore the potential of a cyclohexanetrione to ameliorate retinoid teratogenesis.

Main Methods:

• Administration of selective RAR and RXR ligands to pregnant hamsters during early gestation.
• Assessment of teratogenic potency compared to all-trans-retinoic acid.
• In vitro transcriptional activation assays using human RARs.
• Concomitant administration of a cyclohexanetrione with all-trans-retinoic acid.

Main Results:

• RAR-selective retinoids varied significantly in teratogenic potency, with some being 60-8000 times more potent than all-trans-retinoic acid.
• Retinoids lacking affinity for RAR or RXR receptors showed little developmental toxicity.
• In vitro transactivation potency correlated with in vivo teratogenic potency for some RAR ligands.
• The cyclohexanetrione demonstrated only limited amelioration of retinoid-induced developmental toxicity.

Conclusions:

• Retinoid teratogenesis is strongly dependent on interaction with specific RAR and RXR nuclear receptors.
• Ligands with no affinity for these receptors have minimal teratogenic potential.
• Specific RAR subtypes appear critical in mediating retinoid-induced developmental toxicity.